Business Segments Alkem Laboratories Limited Bombay S.E.

Stocks

ALKEM

INE540L01014

Pharmaceuticals

Market Closed - Bombay S.E. 06:01:12 2026-07-24 EDT 5-day change 1st Jan Change
5,635.60 INR +0.52% Intraday chart for Alkem Laboratories Limited +1.49% +2.37%

Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Net Income: Breakdown by Business Segment

Breakdown by Business Segment (INR)
Fiscal Period: March 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Pharmaceutical Products

          

Pharmaceuticals

88.65B 106B 116B 127B 130B

Total Assets

115B 141B 138B 156B 177B

Interest Expense

-399M -309M -809M -804M -1.05B

Income Tax Expense

2.24B 1.64B 2.98B 2.12B 3.11B

CAPEX

-1.95B -3.39B -2.33B -2.59B -6.76B

EBT

18.42B 18.44B 13.05B 20.23B 25.27B

EBITDA

- - - - -

D&A

2.65B 2.94B 2.99B 2.86B 3.44B

Net Income

15.85B 16.46B 9.84B 17.96B 21.65B

Total Assets

- - - - -

EBT

- - - - -

Interest Expense

- - - - -

Real Estate Operators And Lessors

          

EBITDA

- - - - -

Total Assets

- - - - -

EBT

- - - - -

Interest Expense

- - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (INR)
Fiscal Period: March 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

India

58.21B 75.27B 81.6B 86.62B 91.44B

Total Assets

25.57B 25.9B 25.58B 25.85B 23.87B

CAPEX

- - - - -

United States (US)

24.67B 23.29B 25.13B 27.71B 24.82B

Total Assets

5.84B 5.99B 3.97B 3.98B 9.61B

Other International

5.78B 7.78B 9.26B 12.35B 13.39B

Total Assets

452M 519M 515M 486M 522M

International

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -